Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UbiQD is a private U.S. advanced materials company that develops and manufactures quantum dot nanomaterials for commercial applications in agriculture, solar energy, security, and related industrial markets. Founded in 2014 as a spinout from Los Alamos National Laboratory, the company focuses on heavy-metal-free, low-hazard quantum dots and nanocomposites that can be integrated into existing products as drop-in materials. Its best-known commercial offerings include UbiGro greenhouse products that optimize the light spectrum to improve crop growth, as well as quantum dot solutions for photovoltaic modules and security applications. UbiQD has expanded its solar position through collaboration with First Solar and the 2025 acquisition of BlueDot Photonics. The company appears to be revenue-generating, manufacturing from Los Alamos, New Mexico, and scaling production following a 2025 Series B financing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UbiQD.